Skip to main
CI

Cigna (CI) Stock Forecast & Price Target

Cigna (CI) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 33%
Buy 60%
Hold 7%
Sell 0%
Strong Sell 0%

Bulls say

The Cigna Group is anticipated to experience robust growth driven by its Evernorth segment, which is expected to enhance patient satisfaction, reduce costs, and improve health outcomes. The company projects a recovery in stop loss margins, contributing to Healthcare segment adjusted operating income growth at the higher end of its long-term target of 7%-10%, supported by pricing strategies and selective growth initiatives. Additionally, strong free cash flow is expected to facilitate ongoing capital deployment, allowing Cigna to broaden its service offerings and sustain core growth trends.

Bears say

The financial outlook for Cigna Group appears negative due to anticipated declines in its Evernorth Adjusted Operating Income (AOI), projected to drop from $3,506 million in CY25 to approximately $2,749 million in CY26, representing a year-over-year decrease of $758 million. This decline is attributed to PBM margin headwinds, a transition to a rebate-free model expected to reduce earnings by $500 million to $600 million, and the expectation of a reduction in AOI margins for top customers. Additional challenges include risks related to accurately pricing and managing healthcare cost trends, a slowdown in biosimilar adoption, and potential client losses within the Evernorth segment.

Cigna (CI) has been analyzed by 15 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 60% recommend Buy, 7% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cigna and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cigna (CI) Forecast

Analysts have given Cigna (CI) a Buy based on their latest research and market trends.

According to 15 analysts, Cigna (CI) has a Buy consensus rating as of Mar 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $352.60, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $352.60, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cigna (CI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.